g.bakken
TL2 · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 21 May 2025 · last posted 13h
79 posts, newest first. Showing up to 150.
-
Tracking a shortage from primary sources rather than rumour Replied, post #127 · Access › Shortages · 27 Jul 2026 · 18 likes Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite. Worth saying I have only my own numbers…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #32 · Evidence › Study critique · 26 Jul 2026 · 1 like Building on post #31 rather than restating it. Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #106 · Analytics › Home & field testing · 23 Jul 2026 · 5 likes Taking post #105 at face value and following it one step further. The most useful home practice is not a test at all: photograph the vial, the cake, the label and the…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #31 · Sourcing › Independent verification · 18 Jul 2026 · 8 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #79 · Analytics › Impurities & related substances · 16 Jul 2026 · 30 likes Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost nobody has the documents to do it. That is the practical…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #113 · Outcomes › Body composition · 12 Jul 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #28 · Analytics › HPLC & UHPLC · 11 Jul 2026 · 2 likes Picking up post #27: that is the part I would want checked first. On Detection wavelength the community has more anecdote than the confidence in this thread implies,…
-
Here for the analytics and not much else Replied, post #18 · Lounge › Introductions · 11 Jul 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #40 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 1 like CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #58 · Sourcing › Independent verification · 2 Jul 2026 · 17 likes On Interpreting a result I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
A site rotation scheme that is easy enough to actually follow Replied, post #102 · Practice › Administration · 30 Jun 2026 · 30 likes Reporting rather than recommending, on site rotation scheme. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #4 · Analytics › Mass spectrometry · 28 Jun 2026 · 0 likes Isotope pattern is a check that costs nothing to look at. A species at this molecular weight has a characteristic envelope, and something with the wrong envelope is not…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #68 · Analytics › HPLC & UHPLC · 24 Jun 2026 · 7 likes If two laboratories disagree by more than two or three percentage points, work through method, integration, sample handling, whether it was the same lot and the same…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #22 · Evidence › Trials · 22 Jun 2026 · 21 likes Where I part company with post #18, and it is a narrow parting. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #26 · Research Methods › Statistics · 20 Jun 2026 · 19 likes The most useful thing anyone has posted about Absence of evidence in this category was a table of what had been measured and by whom. That is what I would want again.
-
Request: a per-category review queue Replied, post #38 · Meta › Feature requests · 15 Jun 2026 · 31 likes Coming back to post #34, because the follow-up matters more than the original answer. Reframing per-category review queue slightly, because I think the disagreement is…
-
PCOS and metabolic overlap: what is and is not studied Replied, post #3 · Clinical › Comorbidities · 10 Jun 2026 · 4 likes Adding the measurement that post #2 says would settle it. Age at the extremes of the studied range is an extrapolation in both directions, and the trials generally…
-
The anatomy of a question that gets answered within an hour Replied, post #71 · Start Here › How to Ask · 8 Jun 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Adding it because I spent an afternoon…
-
The best-written scientific paper you have read Replied, post #74 · Lounge › Off topic · 31 May 2026 · 1 like Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #71 · Data & Tools › Datasets · 26 May 2026 · 7 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #74 · Clinical › Bloodwork · 21 May 2026 · 1 like The most useful reply I ever got about Thyroid function tests during substantial was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #22 · Analytics › Method validation · 15 May 2026 · 0 likes Forced degradation under acid, base, oxidation, heat and light is how specificity is actually demonstrated. The chromatograms from that work are more informative than…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #3 · Practice › Dosing & titration · 12 May 2026 · 5 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #115 · Practice › Interactions · 7 May 2026 · 2 likes Marking my place. If it changes for me I will come back and say so.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #15 · Compounds › Tirzepatide · 2 May 2026 · 2 likes Narrowing post #14, because the general version has more than one answer. Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration…
-
Transporting a vial for a weekend away — a second dataset Replied, post #38 · Practice › Storage & stability · 27 Apr 2026 · 0 likes I would put moderate confidence on the mainstream reading of Transporting a vial and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Interim analyses and stopping rules Replied, post #18 · Evidence › Trials · 2 Apr 2026 · 19 likes I had written a reply contradicting post #17 and deleted it. Here is what survived. Absolute and relative effects answer different questions. Write down the event rate…
-
Which fields on a certificate actually matter, ranked Replied, post #13 · Analytics › COA interpretation · 14 Mar 2026 · 27 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Oral versus injected administration claims for BPC-157 Replied, post #6 · Compounds › Repair & healing peptides · 10 Mar 2026 · 0 likes This follows post #3 rather than contradicting it. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group.…
-
The most useful thing you learned here that was not the answer you came for Replied, post #26 · Lounge › Off topic · 10 Mar 2026 · 0 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. Not the whole…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #3 · Compounds › Repair & healing peptides · 6 Mar 2026 · 4 likes A methods point on Reading a preclinical wound-healing model rather than a substantive one: if the comparison is not like for like, the difference you are measuring is…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #35 · Research Methods › N-of-1 designs · 5 Mar 2026 · 7 likes That reframing is the whole thing. The facts I already had.
-
Measurement error in a self-reported exposure Replied, post #77 · Evidence › Study critique · 25 Feb 2026 · 0 likes Where I have landed on measurement error, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #30 · Practice › Administration · 24 Feb 2026 · 15 likes Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this class describes, and the published comparisons found the…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #111 · Access › International · 15 Feb 2026 · 25 likes My position on Language barriers in accessing is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #85 · Sourcing › Independent verification · 18 Jan 2026 · 7 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #8 · Evidence › Trials · 15 Jan 2026 · 3 likes Two things can be true about Non-inferiority margins at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #9 · Evidence › Journal club · 14 Jan 2026 · 17 likes Narrowing post #6, because the general version has more than one answer. The baseline characteristics table is the single most useful page for the questions that get…
-
The headache that turns out to be dehydration Replied, post #130 · Nutrition & Training › Hydration & electrolytes · 9 Jan 2026 · 7 likes Post #128 put the caveat in the right place and I want to underline it. The failure mode on headache is boring rather than dramatic. It is almost always the step…
-
Dead volume across syringe and needle combinations Replied, post #49 · Devices › Syringes & needles · 4 Jan 2026 · 16 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #10 · Practice › Side effects · 1 Jan 2026 · 8 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #79 · Compounds › Semaglutide · 27 Dec 2025 · 4 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
A payment that went through twice: how it was resolved Replied, post #12 · Sourcing › Payments · 23 Dec 2025 · 26 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
How to ask about something you suspect is a bad idea Replied, post #32 · Start Here › How to Ask · 8 Dec 2025 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #86 · Compounds › Tirzepatide · 16 Nov 2025 · 27 likes Something worth flagging about tirzepatide titration schedules: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
-
Early satiety becoming a problem rather than a benefit Replied, post #6 · Practice › Side effects · 6 Nov 2025 · 12 likes One more thing on early satiety that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #5 · Sourcing › Independent verification · 4 Nov 2025 · 0 likes A supplier that supplies a supplementary certificate for a lot released a year ago has demonstrated that its records exist and are retrievable. That is a real property.…
-
What pooling buys you and what it destroys Replied, post #57 · Evidence › Meta-analyses · 3 Nov 2025 · 6 likes Two questions I would want answered before drawing anything from the pooling buys data above: how were the cases selected, and what happened to the ones that dropped out.
-
The headache that turns out to be dehydration Replied, post #39 · Nutrition & Training › Hydration & electrolytes · 30 Oct 2025 · 10 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Documentation that materially improves an appeal's chances Replied, post #37 · Access › Insurance & coverage · 23 Oct 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Which panel is worth repeating and which is worth ignoring Replied, post #130 · Clinical › Bloodwork · 6 Oct 2025 · 4 likes The version of panel that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
-
NHS criteria and how they are applied in practice — the long version Replied, post #4 · Regional › UK & Ireland · 7 Sep 2025 · 3 likes Where I part company with post #2, and it is a narrow parting. Where a service has its own criteria layered on top of national guidance, those are the criteria that…
-
Trial registration and comparing the protocol with the paper Replied, post #36 · Evidence › Trials · 7 Sep 2025 · 6 likes Trial duration determines what can be observed. A weight-change trajectory at 40 weeks and at 72 weeks are different observations and both get quoted as the result.
-
A preprint whose numbers changed substantially at publication Replied, post #39 · Evidence › Preprints · 2 Sep 2025 · 0 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #103 · Data & Tools › Calculators · 2 Sep 2025 · 5 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #124 · Wellbeing › Mental health · 2 Sep 2025 · 0 likes Narrowing post #121, because the general version has more than one answer. History of disordered eating would be much easier to settle if anyone reported the…
-
What this community means by "a source", in practical terms Replied, post #91 · Start Here › Welcome · 29 Aug 2025 · 0 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #23 · Practice › Side effects · 29 Aug 2025 · 24 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #26 · Compounds › Other compounds · 23 Aug 2025 · 1 like The version of catalogue breadth that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #19 · Analytics › COA interpretation · 12 Aug 2025 · 0 likes Adding the measurement that post #18 says would settle it. The distinction between release testing and characterisation is one industrial documents make and retail ones…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #37 · Data & Tools › Calculators · 28 Jun 2025 · 0 likes On titration planner refuses I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #4 · marked as the solution · Research Methods › N-of-1 designs · 16 May 2025 · 14 likes The opening post is right about the mechanism and I think understates the practical bit. Since Designing a personal experiment keeps coming up, it should probably be a…
-
Adjudicated events and why the definition matters — the long version Replied, post #130 · Evidence › Trials · 2 May 2025 · 0 likes Where I part company with post #128, and it is a narrow parting. The figure that circulates in coverage is almost always whichever estimand gives the larger effect.…
-
Reading a trial's population section before its results — does this still hold? Replied, post #29 · Evidence › Trials · 22 Apr 2025 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #57 · Practice › Reconstitution · 14 Apr 2025 · 32 likes Reconstituting a multi-strength kit: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #105 · Analytics › COA interpretation · 21 Mar 2025 · 15 likes My position on Counter-ion form is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #102 · Sourcing › Regulatory · 10 Mar 2025 · 5 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #47 · Pharmacology › Receptor biology · 5 Mar 2025 · 32 likes The arithmetic in post #44 is right; the assumption feeding it is the part to check. GLP-1 receptor agonism produces its metabolic effects through more than one route:…
-
When to suspect the method rather than the sample Replied, post #75 · Analytics › Method validation · 1 Feb 2025 · 1 like On post #71 — agreed on the reasoning, with one qualification. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance.…
-
Recovery when intake is low: what to cut first Replied, post #19 · Nutrition & Training › Resistance training · 10 Jan 2025 · 6 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #18 · Compounds › Tirzepatide · 6 Jan 2025 · 18 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
A promotion I argued against, and why I lost Replied, post #41 · Documentation › Doc review · 26 Dec 2024 · 0 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage.
-
Why "any advice?" is the least effective ending for a post Replied, post #112 · Start Here › How to Ask · 6 Dec 2024 · 0 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Coming back to: When to suspect the method rather than the sample Replied, post #2 · Analytics › Method validation · 26 Nov 2024 · 0 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
UK access routes, dated and sourced — a second dataset Replied, post #2 · Regional › UK & Ireland · 24 Oct 2024 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Waiting times are the most variable and least generalisable thing reported here, and…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #114 · Clinical › Bloodwork · 16 Oct 2024 · 1 like Confirming post #111 from a second method, which matters more than confirming it from a second person. A trend needs at least three points to be a trend. Two points are…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #2 · marked as the solution · Evidence › Journal club · 21 Jul 2024 · 11 likes Everything in the opening post holds. The case it does not cover is the one I have. Reading order that works for these sessions: registry entry, methods, baseline…
-
Cold packs, phase-change material, and what survives ten days Replied, post #35 · Sourcing › Logistics · 22 Jun 2024 · 10 likes Post #34 is the version of this I will quote in future. One addition. Peak periods and public holidays affect this more than any other factor and are entirely…
-
The mass-error checker and its intended scope Replied, post #51 · Data & Tools › Calculators · 15 Jun 2024 · 0 likes Taking post #50 at face value and following it one step further. The most common input error is entering the vial mass in the concentration field. It produces a…